scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1043941435 |
P356 | DOI | 10.1007/S00436-014-4300-3 |
P932 | PMC publication ID | 4336812 |
P698 | PubMed publication ID | 25576191 |
P5875 | ResearchGate publication ID | 270649867 |
P50 | author | Edward Thorp | Q41305505 |
P2093 | author name string | David M Engman | |
Joann M Taylor | |||
Kevin M Bonney | |||
Conrad L Epting | |||
P2860 | cites work | Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 |
Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 | ||
T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation | Q28511506 | ||
Pathogenesis of chagas' disease: parasite persistence and autoimmunity | Q28742827 | ||
CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load | Q33282864 | ||
IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis | Q33532584 | ||
CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice | Q33745170 | ||
Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity | Q33809208 | ||
Regulatory T cells phenotype in different clinical forms of Chagas' disease | Q33927456 | ||
Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. | Q34003026 | ||
Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice | Q34130172 | ||
Parasite polyclonal activators: new targets for vaccination approaches? | Q34240147 | ||
Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease. | Q34251395 | ||
IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils | Q34266045 | ||
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi. | Q35101438 | ||
Control of T cell activation by CD4+CD25+ suppressor T cells | Q35580394 | ||
IL-4 from Th2-type cells suppresses induction of delayed-type hypersensitivity elicited shortly after immunization | Q35592442 | ||
Parasitic diseases of the heart | Q35650927 | ||
Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice | Q35689168 | ||
Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance | Q35703487 | ||
Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism | Q35746981 | ||
Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease | Q35779913 | ||
Mechanisms of suppression by suppressor T cells | Q36078047 | ||
Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of α-galactosyl residues. | Q36080155 | ||
"Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue | Q36107611 | ||
The immunology of experimental Chagas' disease. 3. Rejection of allogeneic heart cells in vitro | Q36273596 | ||
Regulatory T cells in immune surveillance and treatment of cancer. | Q36352546 | ||
Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice | Q36449594 | ||
CD4+ CD25+ FOXP3+ Treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental Chagas disease model | Q36665012 | ||
Role of Th1 and Th17 cells in organ-specific autoimmunity. | Q37172965 | ||
Chagas heart disease pathogenesis: one mechanism or many? | Q37264799 | ||
Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). | Q37467729 | ||
Innate immunity and regulatory T-cells in human Chagas disease: what must be understood? | Q37597066 | ||
Human FoxP3+ regulatory T cells in systemic autoimmune diseases | Q37881234 | ||
Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. | Q38957765 | ||
Trypanosoma Cruzi-Sensitized T-Lymphocyte Mediated 51Cr Release from Human Heart Cells in Chagas' Disease * | Q39522787 | ||
Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response | Q39730057 | ||
Administration of a nondepleting anti-CD25 monoclonal antibody reduces disease severity in mice infected with Trypanosoma cruzi | Q39829243 | ||
CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis | Q40016348 | ||
Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study | Q40649314 | ||
A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins | Q40882932 | ||
Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi | Q41823109 | ||
In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure | Q41849739 | ||
Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity | Q42114995 | ||
Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes | Q42152162 | ||
Modulation of autoimmunity by treatment of an infectious disease | Q42432412 | ||
Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity? | Q42497203 | ||
Parasite persistence correlates with disease severity and localization in chronic Chagas' disease | Q42605133 | ||
Th17 cells in inflammatory conditions | Q42976492 | ||
Cardiac damage induced by immunization with heat-killed Trypanosoma cruzi is not antibody mediated | Q44113294 | ||
CD4+CD25+Foxp3+ regulatory T cells prevent the development of Th1 immune response by inhibition of dendritic cell function during the early stage of Plasmodium yoelii infection in susceptible BALB/c mice. | Q44235863 | ||
Cruzipain induces autoantibodies against cardiac muscarinic acetylcholine receptors. Functional and pathological implications | Q44561352 | ||
Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease | Q44771953 | ||
Regulation of proinflammatory Th17 responses during Trypanosoma cruzi infection by IL-12 family cytokines | Q44973879 | ||
The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. | Q45339719 | ||
Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity. | Q45593876 | ||
The human macrophage mannose receptor is not a professional phagocytic receptor | Q46378486 | ||
Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy | Q47733495 | ||
CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. | Q54139898 | ||
Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease | Q56901414 | ||
Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease | Q57203300 | ||
Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice | Q58842504 | ||
IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | Q58843169 | ||
The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi | Q58844686 | ||
Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology | Q58844932 | ||
Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease | Q58845107 | ||
Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes | Q58845519 | ||
Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas' disease | Q58845899 | ||
Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice | Q58846523 | ||
CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism | Q59387726 | ||
Phagocytosis of unopsonized zymosan by human monocyte-derived macrophages: maturation and inhibition by mannan | Q69845125 | ||
Immunization with the C-terminal region of Trypanosoma cruzi ribosomal P1 and P2 proteins induces long-term duration cross-reactive antibodies with heart functional and structural alterations in young and aged mice | Q73066943 | ||
Echocardiographic and Clinical Predictors of Mortality in Chronic Chagas' Disease | Q73433484 | ||
Captopril prevents experimental autoimmune myocarditis | Q73552878 | ||
Cruzipain induces autoimmune response against skeletal muscle and tissue damage in mice | Q74199971 | ||
CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas | Q79623493 | ||
Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta | Q80358435 | ||
Cardiac parasympathetic abnormalities: Cause or consequence of chagas heart disease? | Q80818267 | ||
Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells | Q82732264 | ||
P433 | issue | 3 | |
P921 | main subject | Chagas disease | Q649558 |
P304 | page(s) | 1167-1178 | |
P577 | publication date | 2015-01-11 | |
P1433 | published in | Parasitology Research | Q15755242 |
P1476 | title | Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease | |
P478 | volume | 114 |
Q40273147 | BATF2 inhibits immunopathological Th17 responses by suppressing Il23a expression during Trypanosoma cruzi infection. |
Q47093622 | Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection. |
Q38599837 | Immunity and immune modulation in Trypanosoma cruzi infection |
Q56895331 | Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis |
Q59136942 | Limited Foxp3 Regulatory T Cells Response During Acute Infection Is Required to Allow the Emergence of Robust Parasite-Specific CD8 T Cell Immunity |
Q57789637 | Pathology and Pathogenesis of Chagas Heart Disease |
Q54255041 | Regulatory Lymphoid and Myeloid Cells Determine the Cardiac Immunopathogenesis of Trypanosoma cruzi Infection. |
Q58705710 | The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease |
Q47162312 | Unconventional Pro-inflammatory CD4+ T Cell Response in B Cell-Deficient Mice Infected with Trypanosoma cruzi. |
Q92471833 | Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model |
Search more.